
Nutriband Inc. Secures U.S. Patent for AVERSA(TM) Technology to Combat Drug Abuse
Nutriband Inc.'s new U.S. patent for its AVERSA(TM) technology marks a significant step forward in preventing the misuse and abuse of transdermal drugs, addressing a critical aspect of the ongoing opioid crisis.
Read full story























